For the Inventor, By the Inventor

Enter assignee name

Brisbane, CA, United States of America

Cellegy Pharmaceuticals Inc.

USPTO Granted Patents = 19

Forward Citations = 606

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Stephen Grayson (7 out of 7 patents)

Carl R Thornfeldt (7 out of 19 patents)

Thomas P Parks (4 out of 9 patents)

4. Vivien H W Mak (4 out of 5 patents)

5. Peter Michael Elias (4 out of 18 patents)

6. Michael A Adams (3 out of 26 patents)

7. Jeremy P W Heaton (3 out of 19 patents)

8. Charles E Lee (3 out of 6 patents)

9. Jung-Chung Lee (3 out of 9 patents)

10. Don R Baker (2 out of 137 patents)

11. Vivien Mak (2 out of 3 patents)

12. Lynne-Marie Postovit (1 out of 5 patents)

13. Charles H Graham (1 out of 4 patents)

14. Donald H Maurice (1 out of 1 patent)

15. Kenneth R Feingold (1 out of 8 patents)

19 patents: Sort by Forward Citations

1. 7157097 - Penetration enhancing and irritation reducing systems (2007-01-02),

2. 6987129 - Compounds and methods for the treatment of urogenital disorders (2006-01-17),

3. 6946484 - Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype (2005-09-20),

4. 6889875 - Taper well meter dose pump (2005-05-10),

5. 6869961 - Store operated calcium influx inhibitors and methods of use (2005-03-22),

6. 6787553 - Methods for remodeling neuronal and cardiovascular pathways (2004-09-07),

7. 6747063 - Combination therapy for treatment of erectile dysfunction (2004-06-08),

8. 6699886 - Store operated calcium influx inhibitors and methods of use (2004-03-02),

9. 6627632 - Compositions and methods for the treatment of anorectal disorders (2003-09-30),

10. 6579865 - Penetration enhancing and irritation reducing systems (2003-06-17),

11. 6482839 - Pyridine-thiols for treatment of a follicular dermatosis (2002-11-19),

12. 6395736 - Compositions and methods for the treatment of anorectal disorders (2002-05-28),

13. 6319913 - Penetration enhancing and irritation reducing systems (2001-11-20),

14. 6071543 - Pyridine-thiols reverse mucocutaneous aging (2000-06-06),

15. 6010691 - Methods for enhancing permeation of a topically administered (2000-01-04),

Cellegy Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of novel therapies for unmet medical needs. With a focus on dermatology and women's health, Cellegy aims to improve the lives of patients through innovative treatments. Visit their website to learn more about their research pipelines, ongoing clinical trials, and commitment to advancing healthcare through scientific excellence.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

19 Patents

#5 in Brisbane, CA

#3,966 in California

#16,595 in US

#31,677 in the World

Brisbane, CA, United States of America

Cellegy Pharmaceuticals Inc.

Forward Citations = 606

15 inventors:

Stephen Grayson (7 out of 7 patents)

Carl R Thornfeldt (7 out of 19 patents)

Thomas P Parks (4 out of 9 patents)

4. Vivien H W Mak (4 out of 5 patents)

5. Peter Michael Elias (4 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…